Sicart Associates’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5,103	Closed	-$414K	–	77
2025 Q1	$414K	Sell	5,103 -200	-4%	-$16.2K	0.14%	53
2024 Q4	$478K	Hold	5,303	–	–	0.17%	51
2024 Q3	$524K	Buy	5,303 +200	+4%	+$19.8K	0.18%	50
2024 Q2	$473K	Hold	5,103	–	–	0.18%	52
2024 Q1	$484K	Buy	5,103 +2,783	+120%	+$264K	0.18%	52
2023 Q4	$207K	Buy	+2,320	New	+$207K	0.08%	67
2022 Q2	–	Sell	-2,320	Closed	-$209K	–	94
2022 Q1	$209K	Hold	2,320	–	–	0.05%	84
2021 Q4	$263K	Sell	2,320 -30	-1%	-$3.4K	0.07%	80
2021 Q3	$295K	Hold	2,350	–	–	0.08%	87
2021 Q2	$318K	Hold	2,350	–	–	0.08%	90
2021 Q1	$319K	Hold	2,350	–	–	0.08%	82
2020 Q4	$331K	Hold	2,350	–	–	0.08%	85
2020 Q3	$262K	Hold	2,350	–	–	0.08%	88
2020 Q2	$263K	Buy	+2,350	New	+$263K	0.08%	90
2020 Q1	–	Sell	-2,350	Closed	-$224K	–	123
2019 Q4	$224K	Buy	+2,350	New	+$224K	0.07%	98
2019 Q3	–	Sell	-3,350	Closed	-$294K	–	119
2019 Q2	$294K	Sell	3,350 -1,200	-26%	-$105K	0.12%	72
2019 Q1	$412K	Sell	4,550 -1,305	-22%	-$118K	0.17%	61
2018 Q4	$420K	Hold	5,855	–	–	0.2%	61
2018 Q3	$561K	Hold	5,855	–	–	0.27%	56
2018 Q2	$557K	Sell	5,855 -1,305	-18%	-$124K	0.29%	58
2018 Q1	$628K	Hold	7,160	–	–	0.38%	55
2017 Q4	$608K	Hold	7,160	–	–	0.32%	62
2017 Q3	$620K	Hold	7,160	–	–	0.44%	48
2017 Q2	$553K	Buy	7,160 +1,200	+20%	+$92.7K	0.4%	50
2017 Q1	$413K	Buy	+5,960	New	+$413K	0.3%	66